RESECTABLE NON-SMALL CELL LUNG CANCER
Clinical trials for RESECTABLE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted attack on lung cancer before surgery: could new drug combo stop recurrence?
Disease control TerminatedThis study aimed to test whether giving a targeted drug called adagrasib, alone or combined with an immunotherapy drug (nivolumab), before surgery could better treat operable non-small cell lung cancer with a specific KRAS G12C mutation. The goal was to see if this approach could…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New Two-Target drug trial aims to shrink tumors before lung cancer surgery
Disease control OngoingThis study is testing a new drug called AK112, which targets two cancer pathways at once. It is given to patients before and after surgery for operable non-small cell lung cancer, either alone or combined with standard chemotherapy. The goal is to see if this approach helps shrin…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control OngoingThis study is testing whether adding an experimental drug called fianlimab to a standard treatment (cemiplimab plus chemotherapy) is more effective for people with early-stage, operable non-small cell lung cancer. The treatment is given before and after surgery. The main goal is …
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC